-
Published on Nov 2, 2016
Erik
Henau, chief executive of Concepta Plc (LON:CPT), speaks with Proactive
Investors’ Stocktube about progress with the fertility group’s Chinese
operations.
Product manufacturing is gearing up in China and the initial trial batch is ready, and they will soon go to a Chinese hospital for testing.
Hanau talks investors through the subsequent distribution, as well as develops for Concepta’s British manufacturing, research and development and hiring efforts.
The company, which essentially specialises in bio-monitoring, has initially focussed of fertility, though … explains that chronic stress represents another potentially significant opportunity for the group’s expertise.
Mobile health and personal health monitoring are key focal points which Henau highlights is a “very big new development” for the industry.
No comments:
Post a Comment